Uganda Clears Twice-Yearly HIV Prevention Shot, Lenacapavir
Kampala — Uganda has approved Lenacapavir, a twice-yearly injectable HIV prevention medicine developed by Gilead Sciences, in a move health officials say could acc...
Kampala — Uganda has approved Lenacapavir, a twice-yearly injectable HIV prevention medicine developed by Gilead Sciences, in a move health officials say could acc...
President Yoweri Kaguta Museveni has pledged to inject Shs1 billion into each mechanics’ Savings and Credit Cooperative Organisation (SACCO) operating within Kampa...
PSA and Testosterone: Are They Linked?Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting screened regularly for...
Around the world, some 40 million people are living with HIV. And though progress in treatment means the infection isn’t the death sentence it once was, researcher...
The Tyne-Wear derby remains one of English football's fiercest rivalries, with Sunderland and Newcastle United battling for bragging rights in the North East for well ove...
Twenty-five years ago, South Africans battled for ARVs to keep people alive. Now the focus has shifted to medicines that can prevent HIV altogether. Health Beat looks how...
Malawi yesterday launched Lenacapavir, a twice-yearly injectable HIV prevention medicine amid reflections on whether the country can sustainably finance emerging technolo...
President Yoweri Kaguta Museveni’s nationwide initiative to economically empower grassroots groups has once again taken centre stage, with 300 brand-new motorcycle...
According to the American Society of Plastic Surgeons, the Brazilian B*tt Lift, better known as a BBL, has become one of the defining cosmetic procedures of the last dec...